They found that sirt1 may serve as a potential pharmacological target for kidney injury (Guan et al., 2017), and that sirt1 activation effectively improves renal fibrosis (Huang et al., 2014), which may be related to the improvement of renal oxidative stress (He et al., 2010). This evidence concerns the gene SIRT1 and renal fibrosis.